A qualitative study of shared decision making related to psychotropic drugs in adolescence
A qualitative study of shared decision making related to psychotropic drugs in adolescence

A qualitative study of shared decision making related to psychotropic drugs in adolescence

Tijdschr Psychiatr. 2024;66(3):125-129.

ABSTRACT

BACKGROUND: Shared decision making (SDM) is an evidence-based model that involves the collaborative development of a treatment plan. SDM in adolescents with mental health problems is complex. Most mental health problems arise in adolescence and psychotropic drugs are an important part of treatment. Previous research focuses primarily on caregivers’ experience with SDM.

AIM: This research has the main objective to gain insight into the adolescents’ experience with shared decision making related to psychotropic drugs.

METHODS: Qualitative research through semi-structured interviews with 12 adolescents (12-18 years old) between June and October 2021, followed by thematic analysis of the data using the systematic text condensation (Malterud).

RESULTS: Four themes were identified in the analysis: 1) the adolescent wants to feel heard, 2) the adolescent needs support in forming and expressing his/her opinion, 3) SDM in adolescents is a complex trialogue, and 4) the decision-making process affects treatment and adherence.

CONCLUSION: When we ask adolescents about their experience with SDM, we can learn the following:- Involve parents, but always tailor this to the individual adolescent and his context. – Put the adolescent at the center. – Dwell on the adolescent’s view on psychotropic drugs.

PMID:38650508